Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
G Ital Nefrol ; 40(3)2023 Jun 29.
Artigo em Italiano | MEDLINE | ID: mdl-37427909

RESUMO

Hemodialysis patients have an increased risk of severe complications when infected with SARS-CoV-2. The introduction of the SARS-CoV-2 vaccine represented an important progress in limiting severe forms of the disease. The focus of our study is the detection of the antibody titer in chronic hemodialysis patients vaccinated with the mRNA vaccine BNT162b2 (Comirnaty, Pfizer-BioNTech). The antibody titers were measured in 57 hemodialysis patients, vaccinated with 3 doses according to ministerial criteria, by ElectroChemiLuminescence ImmunoAssay (ECLIA). The response was defined as an antibody titer above the dosable level > 0,8 UI/ml. A good antibody response was defined as titer > 250 UI/ml. Infections with SARS-CoV-2 and adverse effects to the vaccine were recorded. Our study showed in 93% of the hemodialysis patients a dosable antibody response after the second dose of the vaccine. After the third dose of the vaccine, 100% of the hemodialysis patients reached a dosable antibody titer. The vaccine proved to be safe, no serious adverse events were observed. After the third dose, SARS-CoV-2 infections were still observed, but with reduced severity. A vaccination course against SARS-CoV-2 infection with three doses of BNT162b2 in the dialysis patient is associated with a good immune response and protects against severe infections.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Humanos , Vacinas contra COVID-19/efeitos adversos , Vacina BNT162 , SARS-CoV-2 , COVID-19/prevenção & controle , Diálise Renal , RNA Mensageiro
3.
J Ultrasound ; 26(3): 615-618, 2023 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35107772

RESUMO

INTRODUCTION: Ureteral complications are common in kidney transplanted patients; approximately 2.6-15% of patients develop ureteral obstruction/stenosis at some time after surgery, which is one of the most frequent urologic complications. Inguinal herniation of the neoureter is a rare complication but it must be taken into account. CLINICAL REPORT: We describe the case of a 78-years old male kidney transplanted patient (2004), who was admitted at the emergency room due to abdominal pain and with evidence of acute kidney injury. The ultrasound showed hydronephrosis (grade III) along with ureteral dilatation which ended with an image compatible with a kinking, that was confirmed at the TC and showed that the kneeling was in the right inguinal canal. It was possible, with a manual hernia reduction manoeuvre, to readjust the kneeling of the neoureter resolving the condition temporarily. The patient underwent underwent surgical hernia repair with no complication and complete recovery of renal function. CONCLUSIONS: When ureter obstruction of the transplanted kidney occurs, it is crucial to resolve the obstruction as soon as possible in order to preserve kidney function. Hernioplastic is an effective way to treat ureter obstruction when it is caused by its herniation.


Assuntos
Hérnia Inguinal , Transplante de Rim , Ureter , Obstrução Ureteral , Humanos , Masculino , Idoso , Ureter/diagnóstico por imagem , Ureter/cirurgia , Obstrução Ureteral/diagnóstico por imagem , Obstrução Ureteral/etiologia , Obstrução Ureteral/cirurgia , Transplante de Rim/efeitos adversos , Rim
4.
Front Immunol ; 12: 739430, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34764957

RESUMO

Human complement C4 is one of the most diverse but heritable effectors for humoral immunity. To help understand the roles of C4 in the defense and pathogenesis of autoimmune and inflammatory diseases, we determined the bases of polymorphisms including the frequent genetic deficiency of C4A and/or C4B isotypes. We demonstrated the diversities of C4A and C4B proteins and their gene copy number variations (CNVs) in healthy subjects and patients with autoimmune disease, such as type 1 diabetes, systemic lupus erythematosus (SLE) and encephalitis. We identified subjects with (a) the fastest migrating C4B allotype, B7, or (b) a deficiency of C4B protein caused by genetic mutation in addition to gene copy-number variation. Those variants and mutants were characterized, sequenced and specific techniques for detection developed. Novel findings were made in four case series. First, the amino acid sequence determinant for C4B7 was likely the R729Q variation at the anaphylatoxin-like region. Second, in healthy White subject MS630, a C-nucleotide deletion at codon-755 led to frameshift mutations in his single C4B gene, which was a private mutation. Third, in European family E94 with multiplex lupus-related mortality and low serum C4 levels, the culprit was a recurrent haplotype with HLA-A30, B18 and DR7 that segregated with two defective C4B genes and identical mutations at the donor splice site of intron-28. Fourth, in East-Asian subject E133P with anti-NMDA receptor encephalitis, the C4B gene had a mutation that changed tryptophan-660 to a stop-codon (W660x), which was present in a haplotype with HLA-DRB1*04:06 and B*15:27. The W660x mutation is recurrent among East-Asians with a frequency of 1.5% but not detectable among patients with SLE. A meticulous annotation of C4 sequences revealed clusters of variations proximal to sites for protein processing, activation and inactivation, and binding of interacting molecules.


Assuntos
Doenças Autoimunes/genética , Complemento C4b/genética , Variações do Número de Cópias de DNA , Dosagem de Genes , Imunidade Humoral/genética , Mutação , Doenças Autoimunes/diagnóstico , Doenças Autoimunes/etnologia , Doenças Autoimunes/imunologia , Estudos de Casos e Controles , Complemento C4a/deficiência , Complemento C4a/genética , Complemento C4a/imunologia , Complemento C4b/deficiência , Complemento C4b/imunologia , Feminino , Frequência do Gene , Predisposição Genética para Doença , Humanos , Masculino , Fenótipo
5.
Infez Med ; 25(1): 13-20, 2017 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-28353450

RESUMO

Toxigenic Clostridium difficile is responsible for antibiotic-associated diarrhoea and other diseases. The increasing frequency and severity is attributed to highly-virulent ribotypes such as 027. The aim of the study was to collect epidemiological and molecular data for C. difficile isolates during 2009-2013 in the Central Hospital of Bolzano, Northern Italy. Stool samples from inpatients of the Bolzano Central Hospital were screened for toxins A and B, and C. difficile was cultured and tested for antibiotic susceptibility. PCRs were performed for genes of toxin A, toxin B, binary toxin and ribotyping. During the period 2009-13 from 320 patients (9% of patients tested) at least one stool sample proved positive for C. difficile toxins, and incidences for all hospital inpatients per 10,000 patient days (per 1,000 admissions) varied between 2.2 (1.5) and 4.3 (3.0). Out of 138 isolates (43% of total isolates were studied), 24 different ribotypes were identified. Isolates with ribotype 027 were predominant (38%), followed by 018 (13%) and 607 (10%). Whereas for ribotype 018 a significant decrease was seen during the five-year period, ribotype 027 increased significantly from 0% in 2009 to 64% in 2012, decreasing then to 10% in 2013. Isolates were sensitive to metronidazole and vancomycin, whereas isolates of the three major ribotypes were resistant to moxifloxacin. Our data indicates a significant change in C. difficile incidence rates and ribotype frequencies during the five-year period in the Central Hospital in Bolzano.


Assuntos
Clostridioides difficile/isolamento & purificação , Infecções por Clostridium/diagnóstico , Infecções por Clostridium/epidemiologia , Pacientes Internados/estatística & dados numéricos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Clostridioides difficile/classificação , Clostridioides difficile/genética , Infecções por Clostridium/complicações , Infecções por Clostridium/genética , Diarreia/microbiologia , Farmacorresistência Bacteriana/genética , Feminino , Humanos , Incidência , Itália/epidemiologia , Masculino , Testes de Sensibilidade Microbiana/métodos , Pessoa de Meia-Idade , Estudos Retrospectivos , Ribotipagem
6.
Am J Kidney Dis ; 50(6): 1020-2, 2007 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18037102

RESUMO

A 16-year-old man presented with severe nephrotic syndrome complicated by massive perirenal fluid. Percutaneous drainage of fluid was performed 3 times, followed by improvement in renal function and hypertension, but perirenal fluid recurred within days. Nephrotic syndrome was unresponsive to steroid therapy. A laparoscopic bilateral fenestration of Gerota's fascia and peritoneum allowed permanent drainage of fluid into the peritoneal cavity. During the same procedure, a renal wedge biopsy was performed. Histological examination showed advanced focal glomerular sclerosis of the tip lesion variant. The glomerular disease was refractory to further treatment with cyclophosphamide, mycophenolate, and rituximab. However, perirenal fluid did not recur despite persistent nephrotic syndrome, showing that fenestration of Gerota's fascia is a successful treatment of floating kidneys in such patients.


Assuntos
Líquido Ascítico/fisiologia , Fasciotomia , Glomerulosclerose Segmentar e Focal/complicações , Rim/fisiopatologia , Síndrome Nefrótica/complicações , Adolescente , Biópsia , Glomerulosclerose Segmentar e Focal/patologia , Glomerulosclerose Segmentar e Focal/fisiopatologia , Humanos , Hipertensão Pulmonar/fisiopatologia , Rim/patologia , Laparoscopia/métodos , Masculino , Síndrome Nefrótica/patologia , Síndrome Nefrótica/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...